Recent News

• 03.23.2026 - Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement
• 03.19.2026 - Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical
• 03.19.2026 - Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical
• 02.24.2026 - Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
• 02.24.2026 - Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders

Recent Filings

• 03.23.2026 - 8-K Current report
• 03.23.2026 - RW Registration Withdrawal Request
• 03.23.2026 - 8-K Current report
• 03.23.2026 - EX-99.1 EX-99.1
• 03.19.2026 - 8-K Current report
• 03.19.2026 - EX-99.1 EX-99.1
• 02.24.2026 - 8-K Current report
• 02.24.2026 - SC 13E3/A Going private transaction by certain issuers
• 02.24.2026 - EX-99.1 EX-99.1
• 02.24.2026 - DEFM14A Definitive proxy statement relating to merger or acquisition